AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. ASKA pharmaceutical Co., Ltd.
  3. Financials
  4. Revenue

ASKA pharmaceutical Co., Ltd.【JP:E00929】

Market cap
P/E ratio
SummaryFinancialsDividendsHistorySegmentsWorkforce
Period EndRevenue (Million JPY)YoY (%)
Mar 31, 202052,542+12.50%
Mar 31, 201946,706-4.57%
Mar 31, 201848,944+0.86%
Mar 31, 201748,527+12.29%
Mar 31, 201643,215+0.72%
Mar 31, 201542,907+8.62%
Mar 31, 201439,501-3.57%
Mar 31, 201340,963+0.80%
Mar 31, 201240,637

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)